Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer - Related Studies

Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00080626. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Neoplasms
		Neoplasms by Site
		Skin Diseases

4	Interventions listed in this trial
		docetaxel
		pegfilgrastim
		conventional surgery
		neoadjuvant therapy

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Sidney Kimmel Comprehensive Cancer Center
		National Cancer Institute (NCI)